1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: Interim results from a multicentre, open-label, phase 1b study
    Journal Article

    Sequist, L. V.; Han, J. Y.; Ahn, M. J.; Cho, B. C.; Yu, H.; Kim, S. W.; Yang, J. C. H.; Lee, J. S.; Su, W. C.; Kowalski, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: A multicentre, retrospective, cohort study
    Journal Article

    Myers, K. C.; Furutani, E.; Weller, E.; Siegele, B.; Galvin, A.; Arsenault, V.; Alter, B. P.; Boulad, F.; Bueso-Ramos, C.; Burroughs, L.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: A prospective cohort study from the international T-cell Project
    Journal Article

    Fox, C. P.; Civallero, M.; Ko, Y. H.; Manni, M.; Skrypets, T.; Pileri, S.; Kim, S. J.; Cabrera, M. E.; Shustov, A. R.; Chiattone, C. S.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening
    Journal Article

    Comstock, C. E.; Gatsonis, C.; Newstead, G. M.; Snyder, B. S.; Gareen, I. F.; Bergin, J. T.; Rahbar, H.; Sung, J. S.; Jacobs, C.; Harvey, J. A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Disparities in esophageal cancer: Less treatment, less surgical resection, and poorer survival in disadvantaged patients
    Journal Article

    Schlottmann, F.; Gaber, C.; Strassle, P. D.; Herbella, F. A. M.; Molena, D.; Patti, M. G.
    Diseases of the Esophagus (2020)

    Fulltext@MSK | Save
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Phase Ib study of combination therapy with MEK inhibitor binimetinib and phosphatidylinositol 3-kinase inhibitor buparlisib in patients with advanced solid tumors with RAS/RAF alterations
    Journal Article

    Bardia, A.; Gounder, M.; Rodon, J.; Janku, F.; Lolkema, M. P.; Stephenson, J. J.; Bedard, P. L.; Schuler, M.; Sessa, C.; LoRusso, P.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Intravitreous cutaneous metastatic melanoma in the era of checkpoint inhibition: Unmasking and masquerading
    Journal Article

    Francis, J. H.; Berry, D.; Abramson, D. H.; Barker, C. A.; Bergstrom, C.; Demirci, H.; Engelbert, M.; Grossniklaus, H.; Hubbard, B.; Iacob, C. E.; more...
    Ophthalmology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: Subgroup analyses of a randomized clinical trial
    Journal Article

    Ilson, D. H.; Tabernero, J.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; Thuss-Patience, P.; Beretta, G. D.; Mansoor, W.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma
    Journal Article

    Schlappe, B. A.; Weaver, A. L.; McGree, M. E.; Ducie, J.; Eriksson, A. G. Z.; Dowdy, S. C.; Cliby, W. A.; Glaser, G. E.; Abu-Rustum, N. R.; Mariani, A.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save